sodium phosphate P32, an antineoplastic, antipolycythemic radioactive agent. ▪ INDICATIONS: It is prescribed for treatment of polycythemia vera; for neoplasms, including myelocytic leukemia; and for localizing tumors of the eye. ▪ CONTRAINDICATIONS: Polycythemia vera with leukopenia or decreased platelet count, chronic myelocytic leukemia with leukopenia or erythrocytopenia, concurrent administration of other alkylating agents, or hypersensitivity to this drug prohibits its use. ▪ ADVERSE EFFECTS: The most serious adverse effect is radiation sickness.
